Sunthornthepvarakul T, Kitvitayasak S, Ngowngarmaratana S, Konthong P, Deerochanawong C, Sarinnapakorn V, Phongviratchai S
Department of Medicine, Rajavithi Hospital, Thailand.
J Med Assoc Thai. 1999 Dec;82(12):1214-9.
A polymorphism in codon 52 of the human thyrotropin receptor results in a proline to threonine substitution in the extracellular domain of the receptor, but the association with autoimmune thyroid disease has been uncertain and there is no report the prevalence of this polymorphism in Orientals. To investigate this polymorphism and the association with autoimmune thyroid disease, we studied 113 normal unrelated individuals, 142 autoimmune thyroid disease patients including 112 Graves' disease and 30 Hashimoto's thyroiditis in the Thai population. We screened genomic DNAs of these subjects for the presence of A253 by PCR amplification using a degenerate oligonucleotide primer which produces a Tth111 I restriction site only in the presence of A253. The variant allele was present in 5.3 per cent of normal and 3.5 per cent of autoimmune thyroid disease, 2.7 per cent of Graves' disease and 6.7 per cent of Hashimoto's thyroiditis. The allele distribution in autoimmune thyroid disease patients did not differ significantly from that observed in controls. No association was found between this TSH-R polymorphism and the occurrence of autoimmune thyroid disease.
人类促甲状腺激素受体第52位密码子的多态性导致受体胞外域中的脯氨酸被苏氨酸取代,但该多态性与自身免疫性甲状腺疾病的关联尚不确定,且尚无关于东方人群中这种多态性患病率的报道。为了研究这种多态性及其与自身免疫性甲状腺疾病的关联,我们对泰国人群中的113名正常无亲缘关系个体、142例自身免疫性甲状腺疾病患者进行了研究,其中包括112例格雷夫斯病患者和30例桥本甲状腺炎患者。我们使用简并寡核苷酸引物通过PCR扩增筛选这些受试者的基因组DNA中是否存在A253,该引物仅在存在A253时产生Tth111 I限制性位点。正常个体中变异等位基因的存在率为5.3%,自身免疫性甲状腺疾病患者中为3.5%,格雷夫斯病患者中为2.7%,桥本甲状腺炎患者中为6.7%。自身免疫性甲状腺疾病患者的等位基因分布与对照组中观察到的分布没有显著差异。未发现这种促甲状腺激素受体多态性与自身免疫性甲状腺疾病的发生之间存在关联。